1 Min Read
June 12 (Reuters) - BIOFRONTERA AG
* FILES LABEL EXTENSION FOR AMELUZ IN EU TO INCLUDE TREATMENT WITH DAYLIGHT-PDT FOR ACTINIC KERATOSIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.